Show simple item record

dc.contributor.authorZakeri, Bijan
dc.contributor.authorLu, Timothy K.
dc.date.accessioned2014-09-24T18:01:43Z
dc.date.available2014-09-24T18:01:43Z
dc.date.issued2012-11
dc.date.submitted2012-09
dc.identifier.issn2161-5063
dc.identifier.urihttp://hdl.handle.net/1721.1/90318
dc.description.abstractAntibiotic discovery has a storied history. From the discovery of penicillin by Sir Alexander Fleming to the relentless quest for antibiotics by Selman Waksman, the stories have become like folklore used to inspire future generations of scientists. However, recent discovery pipelines have run dry at a time when multidrug-resistant pathogens are on the rise. Nature has proven to be a valuable reservoir of antimicrobial agents, which are primarily produced by modularized biochemical pathways. Such modularization is well suited to remodeling by an interdisciplinary approach that spans science and engineering. Herein, we discuss the biological engineering of small molecules, peptides, and non-traditional antimicrobials and provide an overview of the growing applicability of synthetic biology to antimicrobials discovery.en_US
dc.description.sponsorshipUnited States. Office of Naval Researchen_US
dc.description.sponsorshipUnited States. Army Research Officeen_US
dc.description.sponsorshipUnited States. Defense Advanced Research Projects Agencyen_US
dc.description.sponsorshipNational Science Foundation (U.S.)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (DP2 OD008435)en_US
dc.description.sponsorshipEllison Medical Foundationen_US
dc.description.sponsorshipMassachusetts Institute of Technology. Institute for Soldier Nanotechnologiesen_US
dc.language.isoen_US
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionofhttp://dx.doi.org/10.1021/sb300101gen_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.titleSynthetic Biology of Antimicrobial Discoveryen_US
dc.typeArticleen_US
dc.identifier.citationZakeri, Bijan, and Timothy K. Lu. “Synthetic Biology of Antimicrobial Discovery.” ACS Synthetic Biology 2, no. 7 (July 19, 2013): 358–372.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Electrical Engineering and Computer Scienceen_US
dc.contributor.departmentMassachusetts Institute of Technology. Research Laboratory of Electronicsen_US
dc.contributor.departmentMassachusetts Institute of Technology. Synthetic Biology Centeren_US
dc.contributor.mitauthorZakeri, Bijanen_US
dc.contributor.mitauthorLu, Timothy K.en_US
dc.relation.journalACS Synthetic Biologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsZakeri, Bijan; Lu, Timothy K.en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-9999-6690
dc.identifier.orcidhttps://orcid.org/0000-0002-4639-7248
mit.licensePUBLISHER_POLICYen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record